ICAD Inc
NASDAQ:ICAD
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1.19
2.4
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one ICAD stock under the Base Case scenario is 2.05 USD. Compared to the current market price of 2.4 USD, ICAD Inc is Overvalued by 15%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
ICAD Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for ICAD cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
ICAD Inc
Balance Sheet Decomposition
ICAD Inc
Current Assets | 27.8m |
Cash & Short-Term Investments | 20.4m |
Receivables | 5.4m |
Other Current Assets | 2.1m |
Non-Current Assets | 11.1m |
PP&E | 2.1m |
Intangibles | 8.5m |
Other Non-Current Assets | 579k |
Current Liabilities | 6.6m |
Accounts Payable | 501k |
Accrued Liabilities | 2.7m |
Other Current Liabilities | 3.3m |
Non-Current Liabilities | 1.4m |
Other Non-Current Liabilities | 1.4m |
Earnings Waterfall
ICAD Inc
Revenue
|
18.8m
USD
|
Cost of Revenue
|
-2.6m
USD
|
Gross Profit
|
16.2m
USD
|
Operating Expenses
|
-21.3m
USD
|
Operating Income
|
-5.1m
USD
|
Other Expenses
|
2.9m
USD
|
Net Income
|
-2.3m
USD
|
Free Cash Flow Analysis
ICAD Inc
USD | |
Free Cash Flow | USD |
iCAD Inc. reported a 21% increase in Q2 2024 revenue to $5 million. Product revenue soared by 41% to $3.3 million, despite a 5% decline in service revenue. The company's new ProFound Cloud platform has exceeded expectations, securing multiple deals and highlighting the shift towards a SaaS model. As a result, iCAD expects stronger economic returns and greater revenue visibility through recurring revenue models. The company saw its GAAP net loss decrease to $1.7 million from $2.3 million, with a gross profit margin improving to 84%. This growth and transformation are projected to drive enhanced profitability in the long term.
What is Earnings Call?
ICAD Profitability Score
Profitability Due Diligence
ICAD Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
Score
ICAD Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
ICAD Solvency Score
Solvency Due Diligence
ICAD Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.
Score
ICAD Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ICAD Price Targets Summary
ICAD Inc
According to Wall Street analysts, the average 1-year price target for ICAD is 4.93 USD with a low forecast of 2.53 USD and a high forecast of 9.45 USD.
Dividends
Current shareholder yield for ICAD is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
ICAD Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
iCAD, Inc. is a medical technology company, which engages in the provision cancer detection and therapy solutions. The company is headquartered in Nashua, New Hampshire and currently employs 136 full-time employees. The firm operates through two segments: Cancer Detection (Detection) and Cancer Therapy (Therapy). In the Detection segment, the Company’s solutions include advanced image analysis and workflow solutions enables healthcare professionals to serve patients by identifying pathologies and pinpointing the prevalent cancers earlier, and a comprehensive range of artificial intelligence and computer aided detection (CAD) systems and workflow solutions for two-dimension(2D) and third dimension (3D) mammography, magnetic resonance imaging (MRI) and computed tomography (CT). In the Therapy segment, the Company offers the Xoft System, an isotope-free cancer treatment platform technology. The Xoft System can be used for the treatment of early-stage breast cancer, endometrial cancer, cervical cancer and nonmelanoma skin cancer.
Contact
IPO
Employees
Officers
The intrinsic value of one ICAD stock under the Base Case scenario is 2.05 USD.
Compared to the current market price of 2.4 USD, ICAD Inc is Overvalued by 15%.